ACQUISITION OF CLASSICAL SWINE FEVER VACCINES

This tender concerns the acquisition of vaccines against Classical Swine Fever (CSF), a highly contagious viral disease affecting domestic and wild pigs. The procurement is being managed by the National Agrarian Health Service (Servicio Nacional de Sanidad Agraria - SENASA), a key governmental body responsible for animal health and agricultural safety in Peru. The tender, identified by the reference number LP-SM-6-2025-SENASA-1, is being conducted through a Public Bidding process, indicating a competitive procurement method. The vaccines are intended for use within the Lima department. The objective is to secure a reliable supply of high-quality CSF vaccines to support national efforts in controlling and eradicating this significant animal disease. This initiative is crucial for protecting the swine population, preventing economic losses for farmers, and ensuring food security. Potential bidders are expected to meet stringent quality standards and demonstrate their capacity to supply the required quantities of vaccines. Further details regarding technical specifications, delivery timelines, and evaluation criteria will be provided in the full tender documentation. SENASA's commitment to safeguarding animal health underscores the importance of this procurement for the agricultural sector.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 2.3 million.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.